Literature DB >> 20219659

Antitussive and central respiratory depressant effects of Stemona tuberosa.

Yan-Tong Xu1, Pang-Chui Shaw, Ren-Wang Jiang, Po-Ming Hon, Yiu-Man Chan, Paul Pui-Hay But.   

Abstract

AIMS OF THE STUDY: Stemona alkaloids with distinctly different chemical skeletons are recently reported as the active components in the antitussive herb Baibu derived from the root-tubers of Stemona tuberosa. This study aims to determine if alkaloids of this herb contribute equally to the antitussive functions, act on the same sites of cough reflex, and play any role in inducing central respiratory depressant effects.
MATERIALS AND METHODS: Antitussive potency of four major alkaloids was evaluated on guinea pigs with citric acid aerosol to induce cough. The action sites of the alkaloids on cough reflex pathway were tested with electrical stimulation of the superior laryngeal nerve in guinea pigs. The central respiratory effects of croomine were also tested on guinea pigs.
RESULTS: Croomine, neotuberostemonine and stemoninine showed similar antitussive potency, while tuberostemonine showed much weaker antitussive potency. Neotuberostemonine, tuberostemonine and stemoninine acted on the peripheral cough reflex pathway, while croomine acted on the central part. Croomine also showed obvious central respiratory depressant effects.
CONCLUSIONS: The four major Stemona alkaloids in Stemona tuberosa do not contribute equally to antitussive potency in guinea pigs. Neotuberostemonine, tuberostemonine and stemoninine target on peripheral cough reflex pathway. Croomine acts on central sites in the cough reflex pathway and demonstrates central respiratory depressant effects, which can partly account for the adverse reactions reported for the herb. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20219659     DOI: 10.1016/j.jep.2010.02.018

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  7 in total

1.  Therapeutic effects of stemonine on particulate matter 2.5-induced chronic obstructive pulmonary disease in mice.

Authors:  Jinbo Zhang; Shiqing Li; Li Sun; Yanxia Chen; Lei Zhang; Zhenghui Zhang
Journal:  Exp Ther Med       Date:  2017-09-01       Impact factor: 2.447

2.  Neotuberostemonine inhibits the differentiation of lung fibroblasts into myofibroblasts in mice by regulating HIF-1α signaling.

Authors:  Xin-Miao Lv; Ming-Dan Li; Si Cheng; Bao-Lin Liu; Kang Liu; Chao-Feng Zhang; Xiang-Hong Xu; Mian Zhang
Journal:  Acta Pharmacol Sin       Date:  2018-04-12       Impact factor: 6.150

3.  Tuberostemoamide hemihydrate.

Authors:  Rong-Rong Zhang; Zhi-Guo Ma; Guo-Qiang Li; Paul Pui-Hay But; Ren-Wang Jiang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-10-29

4.  Inhibitory effects of Stemona tuberosa on lung inflammation in a subacute cigarette smoke-induced mouse model.

Authors:  Hyeonhoon Lee; Kyung-Hwa Jung; Soojin Park; Yun-Seo Kil; Eun Young Chung; Young Pyo Jang; Eun-Kyoung Seo; Hyunsu Bae
Journal:  BMC Complement Altern Med       Date:  2014-12-20       Impact factor: 3.659

5.  Simultaneous quantification of six alkaloid components from commercial stemonae radix by solid phase extraction-high-performance liquid chromatography coupled with evaporative light scattering detector.

Authors:  Rong-Rong Zhang; Dan-Yi Lu; Zhen-Ya Yang; Wen Zhao; Paul Pui-Hay But; Pang-Chui Shaw; Ren-Wang Jiang; Zhi-Guo Ma
Journal:  Pharmacogn Mag       Date:  2015 Apr-Jun       Impact factor: 1.085

6.  Antitussive activity of Pseudostellaria heterophylla (Miq.) Pax extracts and improvement in lung function via adjustment of multi-cytokine levels.

Authors:  Wensheng Pang; Siding Lin; Qiwen Dai; Hongcheng Zhang; Juan Hu
Journal:  Molecules       Date:  2011-04-19       Impact factor: 4.411

7.  Epibisde-hydro-neotuberostemonine J.

Authors:  Lu Jin; Rong-Rong Zhang; Hai-Yan Tian; Paul Pui-Hay But; Ren-Wang Jiang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-08-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.